back to top

We’ve updated our privacy notice and cookie policy. Learn more about cookies, including how to disable them, and find out how we collect your personal data and what we use it for.

This Little Girl's Family Say They Have To Sell Their House Because The NHS Won't Give Her The Drugs She Needs

Bethany Henry's father told BuzzFeed News that he is doing "everything I can" to get his daughter the drugs.

Posted on

This is Bethany, 9, with her father and mother, Luke and Stephanie Henry.

Brighton Argus / Brighton Argus / Solent News

Bethany suffers from a condition called called tuberous sclerosis. Her father described the effects to BuzzFeed News, saying: "It causes benign tumours that can be cancerous. Due to the tumours on her brain she has a mental age of 5. She's on the autism spectrum, suffers from insomnia, and is incontinent."

Speaking about the 50 epileptic fits his daughter suffers a day as a result of the tumours, Henry told The Mirror: "As a parent it's horrendous to watch your baby suffering and for no one to know what it is. Now she hardly sleeps and every single night she's screaming in pain."

The family are attempting to acquire a drug called everolimus to treat Bethany's condition.

The NHS website says it "may be a useful new treatment". Henry said: "It would do everything – it can stop the cells that cause the tumours, and shrink them."

However, the family said that thus far, they haven't been able to acquire it. Henry told us that there have been two applications for the drugs by the doctors treating his daughter, but they have both been turned down.

Two years' worth of drugs would cost around £30,000. "We're doing anything we can," Henry said. "We've set up market stalls and an online funding page, but we've reached a dead end."

BuzzFeed News contacted NHS England to find out why the money hadn't been provided. A spokesperson said:

No new treatments are made routinely available on the NHS without having been approved by NICE or forming part of a NHS England clinical commissioning policy.

NHS England is considering the formation of clinical policy on Everolimus for a number of indications as part of our work programme for the coming year, along with a large number of other competing priorities, including working with NICE to determine whether any of those indications will be included in their work programme.

In the interim, the Individual Funding Request route remains open to clinicians for patients with exceptional need.

The "Individual Funding Request" mentioned in the statement is a way for patients to acquire drugs when their need for them is critical: An application can be made by a patient's specialist to a regional Individual Funding Request panel.

NHS England would not confirm whether such an application by the Henry family was rejected. However, the body told us 19 applications for everolimus have been made in the Henrys' region, the south, over the last two years – seven were accepted, seven were referred to a different region, and the remaining five were not accepted.

Alan White is a news editor for BuzzFeed News and is based in London.

Contact Alan White at

Got a confidential tip? Submit it here.